ICON Announces Publication of EGM Circular in Respect of Proposed Conversion to Direct Listing of its Shares on NASDAQ
2012年11月17日 - 12:00AM
ビジネスワイヤ(英語)
ICON plc, (NASDAQ: ICLR) (ISIN:IE0005711209), a
global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries, today
announced the publication and filing of a circular to shareholders
convening an extraordinary general meeting to be held at 3.00 p.m.
on December 17, 2012 at ICON plc Headquarters, South County
Business Park, Leopardstown, Dublin 18, Ireland at which
resolutions in connection with the proposed replacement of ICON’s
NASDAQ listing for ADSs with a direct NASDAQ listing for ICON
Shares will be considered and voted on.
The expected timetable in respect of the proposals is as
follows:
Latest time and date for receipt of Forms of Proxy for Ordinary
Shareholders for Extraordinary General Meeting
13 December 2012
(6 p.m. GMT)
Extraordinary General Meeting 17 December 2012 (3 p.m. GMT)
Expected last day of dealings in Shares on Irish Stock Exchange 29
January 2013
Expected date of Irish Stock Exchange
Delisting with effect from 6.30 a.m. (GMT)
30 January 2013 Expected date of commencement of direct trading of
Shares on NASDAQ 4 February 2013
A copy of the Circular is available in the investor relations
section of ICON’s website at
http://investor.iconplc.com/proxy.cfm.
A copy of the Circular is also being submitted to the Irish
Stock Exchange, and will shortly be available for inspection
at:
Company Announcements Office,Irish Stock Exchange,28 Anglesea
Street,Dublin 2,Ireland.
Defined terms used in this announcement have the same meaning as
in the Circular unless otherwise stated.
The information contained in this release is as of November 16th
2012. ICON assumes no obligation to update forward-looking
statements contained in this release. A description of risks and
uncertainties relating to ICON and its business can be found in
ICON’s Annual Report and Form 20-F for the fiscal year ended
December 31, 2011 and in its Reports of Foreign Issuer on Form 6-K
filed with the US Securities and Exchange Commission.
ICON plc is a global provider of outsourced development services
to the pharmaceutical, biotechnology and medical device industries.
The company specialises in the strategic development, management
and analysis of programs that support clinical development - from
compound selection to Phase I-IV clinical studies. With
headquarters in Dublin, Ireland, ICON currently, operates from 82
locations in 40 countries and has approximately 9,430 employees.
Further information is available at http://www.iconplc.com.
Source: ICON plc
ICON/ICLR-F
ICON (NASDAQ:ICLR)
過去 株価チャート
から 7 2024 まで 8 2024
ICON (NASDAQ:ICLR)
過去 株価チャート
から 8 2023 まで 8 2024